PACLITAXELUM ACCORD
Concentrate for solution for infusion, 6mg/ml
RestrictedActive license
Active substance (INN)
paclitaxel
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength6mg/ml
PackagingUkupno 1 bočica staklena sa 5ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAccord Healthcare Polska Sp. z o.o., Poland
Therapeutic groupAntineoplastic and immunomodulating agents (L01CD01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateDecember 27, 2022
Analogs in Montenegro
8Other medicines with the same active substance
ABRAXANERx
Powder for dispersion for infusion, 5mg/mlPACLITAXEL EBEWERx
Concentrate for solution for infusion, 100mg/16.7mlPACLITAXEL EBEWERx
Concentrate for solution for infusion, 30mg/5mlPACLITAXELUM ACCORDRx
Concentrate for solution for infusion, 6mg/mlPATAXELRx
Concentrate for solution for infusion, 100mg/16.7mlPATAXELRestricted
Concentrate for solution for infusion, 30mg/5mlSINDAXEL®Rx
Concentrate for solution for infusion, 30mg/5mlSINDAXEL®Rx
Concentrate for solution for infusion, 100mg/16.67mlSource: CInMED register